Total Payments
$308,894
2024 Payments
$23,247
Companies
27
Transactions
374
Medicare Patients
13,050
Medicare Billing
$1.4M
Payment Breakdown by Category
Other$171,412 (55.5%)
Consulting$112,980 (36.6%)
Education$12,851 (4.2%)
Food & Beverage$8,498 (2.8%)
Travel$3,102 (1.0%)
Gifts$45.00 (0.0%)
Research$5.43 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $112,980 | 46 | 36.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $66,012 | 29 | 21.4% |
| Honoraria | $57,300 | 21 | 18.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $30,250 | 15 | 9.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $17,850 | 6 | 5.8% |
| Education | $12,851 | 24 | 4.2% |
| Food and Beverage | $8,498 | 205 | 2.8% |
| Travel and Lodging | $3,102 | 26 | 1.0% |
| Gift | $45.00 | 1 | 0.0% |
| Unspecified | $5.43 | 1 | 0.0% |
Payments by Type
General
$308,888
373 transactions
Research
$5.43
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Beaver-Visitec International, Inc. | $58,344 | 10 | $0 (2024) |
| Iridex Corporation | $52,932 | 22 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $50,072 | 82 | $0 (2021) |
| Aerie Pharmaceuticals, Inc. | $41,652 | 38 | $0 (2021) |
| NEOMEDIX CORPORATION | $27,150 | 16 | $0 (2018) |
| Bausch & Lomb Americas Inc. | $19,506 | 29 | $0 (2024) |
| Allergan, Inc. | $18,167 | 46 | $0 (2021) |
| Alcon Vision LLC | $12,421 | 26 | $0 (2024) |
| Microsurgical Technology, Inc. | $9,050 | 1 | $0 (2020) |
| Glaukos Corporation | $5,974 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,247 | 33 | Bausch & Lomb Americas Inc. ($14,972) |
| 2023 | $19,170 | 52 | Iridex Corporation ($10,200) |
| 2022 | $45,280 | 40 | Iridex Corporation ($28,550) |
| 2021 | $51,811 | 52 | Aerie Pharmaceuticals, Inc. ($24,618) |
| 2020 | $41,388 | 37 | Beaver-Visitec International, Inc. ($10,500) |
| 2019 | $48,097 | 69 | Bausch & Lomb, a division of Bausch Health US, LLC ($16,771) |
| 2018 | $38,829 | 66 | Bausch & Lomb, a division of Bausch Health US, LLC ($20,461) |
| 2017 | $41,071 | 25 | NEOMEDIX CORPORATION ($21,950) |
All Payment Transactions
374 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Beaver-Visitec International, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 12/18/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,800.00 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $492.95 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $211.22 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $191.82 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Travel and Lodging | Cash or cash equivalent | $81.22 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Ophthalmology | ||||||
| 11/08/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Dry eyes | ||||||
| 11/07/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), VYZULTA | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Ophthalmology | ||||||
| 10/22/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Dry eyes | ||||||
| 10/07/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO, LOTEMAX SM | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Ophthalmology | ||||||
| 09/23/2024 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Clearpath, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Ophthalmology | ||||||
| 09/11/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/21/2024 | Iridex Corporation | — | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| 06/12/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Ophthalmology | ||||||
| 06/04/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Ophthalmology | ||||||
| 06/04/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Consulting Fee | Cash or cash equivalent | $325.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/22/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $123.86 | General |
| Category: Ophthalmology | ||||||
| 05/03/2024 | Iridex Corporation | — | Honoraria | Cash or cash equivalent | $2,500.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma Gold-Standard Pathway Study GPS | Allergan Inc. | $5.43 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,633 | 4,330 | $3.1M | $346,968 |
| 2022 | 23 | 3,328 | 4,137 | $3.3M | $372,142 |
| 2021 | 22 | 3,297 | 4,195 | $3.5M | $397,742 |
| 2020 | 20 | 2,792 | 3,479 | $2.7M | $302,613 |
Total Patients
13,050
Total Services
16,141
Medicare Billing
$1.4M
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 985 | 1,547 | $897,260 | $105,490 | 11.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 734 | 772 | $358,335 | $36,764 | 10.3% |
| 65820 | Incision to improve eye fluid flow | Facility | 2023 | 37 | 41 | $207,050 | $30,510 | 14.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 273 | 275 | $229,625 | $29,339 | 12.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 928 | 972 | $353,140 | $26,678 | 7.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 212 | 230 | $197,340 | $24,078 | 12.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 47 | 57 | $244,815 | $20,414 | 8.3% |
| 66180 | Creation of shunt to improve eye fluid flow using tissue graft | Facility | 2023 | 16 | 16 | $122,160 | $15,425 | 12.6% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 47 | 51 | $114,240 | $14,481 | 12.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 82 | 82 | $111,520 | $14,313 | 12.8% |
| 66185 | Revision of eye fluid drainage shunt with graft | Facility | 2023 | 11 | 11 | $62,535 | $7,868 | 12.6% |
| 66710 | Destruction of lens tissue using laser | Facility | 2023 | 17 | 20 | $60,783 | $6,820 | 11.2% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 24 | 26 | $49,530 | $5,166 | 10.4% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 79 | 84 | $50,840 | $2,998 | 5.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 36 | $18,288 | $2,613 | 14.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $18,445 | $1,916 | 10.4% |
| 92134 | Imaging of retina | Office | 2023 | 27 | 29 | $10,155 | $843.08 | 8.3% |
| 92250 | Photography of the retina | Office | 2023 | 19 | 19 | $8,645 | $591.74 | 6.8% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 15 | 15 | $2,700 | $373.35 | 13.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 30 | 30 | $3,600 | $286.06 | 7.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 1,143 | 1,867 | $1.1M | $126,713 | 11.7% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 76 | 94 | $403,730 | $36,733 | 9.1% |
| 65820 | Incision to improve eye fluid flow | Facility | 2022 | 42 | 47 | $237,350 | $34,527 | 14.5% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 652 | 669 | $297,705 | $31,717 | 10.7% |
| 66180 | Creation of shunt to improve eye fluid flow using tissue graft | Facility | 2022 | 24 | 25 | $190,875 | $25,146 | 13.2% |
About Dr. Brian Francis, M.D
Dr. Brian Francis, M.D is a Ophthalmology healthcare provider based in Fountain Valley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427118348.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Francis, M.D has received a total of $308,894 in payments from pharmaceutical and medical device companies, with $23,247 received in 2024. These payments were reported across 374 transactions from 27 companies. The most common payment nature is "Consulting Fee" ($112,980).
As a Medicare-enrolled provider, Francis has provided services to 13,050 Medicare beneficiaries, totaling 16,141 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Glaucoma Specialist
- Location Fountain Valley, CA
- Active Since 12/11/2006
- Last Updated 01/22/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1427118348
Products in Payments
- VYZULTA (Drug) $69,858
- Trabectome (Device) $26,850
- rocklatan (Drug) $26,393
- rhopressa (Drug) $17,553
- Rhopressa (Drug) $7,763
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $5,474
- IYUZEH (Drug) $3,981
- DURYSTA (Drug) $3,608
- Hydrus Microstent (Device) $3,211
- LUMIGAN (Drug) $3,065
- XEN (Device) $2,119
- Hydrus (Device) $1,500
- iStent inject Trabecular Micro-Bypass Stent System (Device) $500.00
- Ahmed Glaucoma Valve (Device) $335.59
- Goniotome (Device) $300.00
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $284.22
- LOTEMAX GEL (Drug) $193.39
- Rocklatan (Drug) $174.66
- Centurion (Device) $164.18
- XIIDRA (Drug) $146.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Fountain Valley
Jared Younger, Md, Mph, MD, MPH
Ophthalmology — Payments: $80,399
Ophthalmology $80,399
Michael Tran, M.d, M.D
Ophthalmology — Payments: $33,907
Ophthalmology $33,907
Dr. Trung Nguyen, M.d, M.D
Ophthalmology — Payments: $31,140
Ophthalmology $31,140
Dr. Tri Nguyen, M.d, M.D
Ophthalmology — Payments: $17,203
Ophthalmology $17,203
Dr. Vicki Lin, M.d, M.D
Ophthalmology — Payments: $14,631
Ophthalmology $14,631
Lee Novick, M.d, M.D
Ophthalmology — Payments: $9,618
Ophthalmology $9,618